ECPC has been invited to participate in the Scientific Advisory Board of TRANSCAN-2 research EU funded project where it will be represented by its Vice-President, Kathi Apostolidis.

TRANSCAN-2 is the continuation of the ERA-NET on Translational Cancer Research (TRANSCAN), an initiative funded by the European Commission’s ERA-NET scheme under the EU Framework Programme for Research and Innovation Horizon 2020 Societal Challenge: Health, Demographic Change and Wellbeing.

The objective of TRANSCAN-2 is to contribute to the building of the European Research Area through the coordination of national and regional translational cancer research funding organisations’ activities, aiming at the integration of basic, clinical and epidemiological cancer research and facilitation of transnational cancer funding in Europe.

We congratulate Mrs Apostolidis for the relevant success!

You can find more information on TRANSCAN-2 clicking here.